PortfoliosLab logoPortfoliosLab logo
PLTK vs. EBS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PLTK vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PLTK achieves a 2.78% return, which is significantly higher than EBS's -40.05% return.


PLTK

1D
1.75%
1M
4.91%
6M
13.09%
YTD
2.78%
1Y
0.35%
3Y*
-24.94%
5Y*
-27.07%
10Y*
ALL TIME*
-29.70%

EBS

1D
2.63%
1M
-10.51%
6M
-36.72%
YTD
-40.05%
1Y
31.62%
3Y*
0.45%
5Y*
-34.62%
10Y*
-12.99%
ALL TIME*
-2.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$3.86M$5.14M$6.60M
$4.60M$4.99M$5.46M

PLTK vs. EBS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
PLTK
Playtika Holding Corp.
2.78%-37.16%-16.05%2.47%-50.78%-48.23%
EBS
Emergent BioSolutions Inc.
-40.05%29.29%298.33%-79.68%-72.83%-58.99%

Correlation

The correlation between PLTK and EBS is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.27

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.27

Correlation (All Time)
Calculated using the full available price history since Jan 15, 2021

0.27

The correlation between PLTK and EBS shifts across timeframes, from 0.13 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PLTK:

$1.54B

EBS:

$382.33M

EPS

PLTK:

-$0.79

EBS:

-$0.41

PS Ratio

PLTK:

0.54

EBS:

0.41

Total Revenue (TTM)

PLTK:

$2.79B

EBS:

$676.80M

Gross Profit (TTM)

PLTK:

$2.04B

EBS:

$292.40M

EBITDA (TTM)

PLTK:

$144.30M

EBS:

$126.60M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PLTK vs. EBS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PLTK
PLTK Risk / Return Rank: 4444
Overall Rank
PLTK Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
PLTK Sortino Ratio Rank: 4444
Sortino Ratio Rank
PLTK Omega Ratio Rank: 4343
Omega Ratio Rank
PLTK Calmar Ratio Rank: 4444
Calmar Ratio Rank
PLTK Martin Ratio Rank: 4444
Martin Ratio Rank

EBS
EBS Risk / Return Rank: 6161
Overall Rank
EBS Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
EBS Sortino Ratio Rank: 6464
Sortino Ratio Rank
EBS Omega Ratio Rank: 6666
Omega Ratio Rank
EBS Calmar Ratio Rank: 6060
Calmar Ratio Rank
EBS Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PLTK vs. EBS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PLTKEBSDifference
Sharpe ratioReturn per unit of total volatility

-0.39

Sortino ratioReturn per unit of downside risk

-0.83

Omega ratioGain probability vs. loss probability

1.05

1.17

-0.12

Calmar ratioReturn relative to maximum drawdown

0.01

0.66

-0.65

Martin ratioReturn relative to average drawdown

0.02

1.11

-1.09

PLTK vs. EBS - Sharpe Ratio Comparison

The current PLTK Sharpe Ratio is 0.01, which is lower than the EBS Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of PLTK and EBS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PLTK vs. EBS - Drawdown Comparison

The maximum PLTK drawdown since its inception was -90.76%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for PLTK and EBS.


Loading charts...

Drawdown Indicators


PLTKEBSDifference

Max Drawdown

Largest peak-to-trough decline

-90.76%

-98.89%

+8.13%

Max Drawdown (1Y)

Largest decline over 1 year

-36.19%

-48.06%

+11.87%

Max Drawdown (3Y)

Largest decline over 3 years

-71.67%

-79.73%

+8.06%

Max Drawdown (5Y)

Largest decline over 5 years

-89.33%

-97.67%

+8.34%

Max Drawdown (10Y)

Largest decline over 10 years

-98.89%

Current Drawdown

Current decline from peak

-86.21%

-94.51%

+8.30%

Average Drawdown

Average peak-to-trough decline

-66.50%

-41.54%

-24.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.29%

28.63%

-10.34%

Volatility

PLTK vs. EBS - Volatility Comparison

Playtika Holding Corp. (PLTK) has a higher volatility of 20.34% compared to Emergent BioSolutions Inc. (EBS) at 10.41%. This indicates that PLTK's price experiences larger fluctuations and is considered to be riskier than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PLTKEBSDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.34%

10.41%

+9.93%

Volatility (6M)

Calculated over the trailing 6-month period

45.75%

46.11%

-0.36%

Volatility (1Y)

Calculated over the trailing 1-year period

55.75%

80.60%

-24.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.94%

102.34%

-50.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

50.73%

79.81%

-29.08%

Dividends

PLTK vs. EBS - Dividend Comparison

PLTK's dividend yield for the trailing twelve months is around 4.93%, while EBS has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
EBS
Emergent BioSolutions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%
PLTK
Playtika Holding Corp.
4.93%10.13%5.76%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PLTK vs. EBS - Financials Comparison

This section allows you to compare key financial metrics between Playtika Holding Corp. and Emergent BioSolutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

PLTK vs. EBS - Profitability Comparison

The chart below illustrates the profitability comparison between Playtika Holding Corp. and Emergent BioSolutions Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

PLTK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Playtika Holding Corp. reported a gross profit of 552.50M and revenue of 744.70M. Therefore, the gross margin over that period was 74.2%.

EBS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Emergent BioSolutions Inc. reported a gross profit of 61.20M and revenue of 156.10M. Therefore, the gross margin over that period was 39.2%.

PLTK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Playtika Holding Corp. reported an operating income of -49.60M and revenue of 744.70M, resulting in an operating margin of -6.7%.

EBS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Emergent BioSolutions Inc. reported an operating income of 0.00 and revenue of 156.10M, resulting in an operating margin of 0.0%.

PLTK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Playtika Holding Corp. reported a net income of -57.50M and revenue of 744.70M, resulting in a net margin of -7.7%.

EBS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Emergent BioSolutions Inc. reported a net income of 0.00 and revenue of 156.10M, resulting in a net margin of 0.0%.


Frequently Asked Questions


PLTK and EBS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PLTK has higher volatility (20.34%) compared to EBS (10.41%). In terms of maximum drawdown, PLTK dropped -90.76% vs EBS's -98.89%.

EBS currently has the higher Sharpe Ratio (0.39 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PLTK and EBS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer